View Older Stories

Jun 18, 2026 05:47AM Oral Wegovy reaches 33% of total prescriptions by May

Jun 15, 2026 04:09PM Raymond James Starts Aktis Oncology (AKTS) at Strong Buy (correction)

Jun 15, 2026 10:11AM BMO Capital on Eli Lilly (LLY): 'Early Data for AJ1-11095 Impress at EHA'

Jun 14, 2026 08:05AM Lilly's Jaypirca reduces disease progression risk by 45% in CLL study

Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day

Jun 9, 2026 02:31PM Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows

Jun 8, 2026 02:31PM Lilly's oral diabetes drug outperforms rival in late-stage trials

Jun 8, 2026 09:40AM Bernstein SocGen Reiterates Outperform Rating on Eli Lilly (LLY)

Jun 8, 2026 09:21AM Truist on Eli Lilly (LLY): 'We see near-term and longer-term areas for growth'

Jun 8, 2026 02:56AM Lilly reports weight loss data for Foundayo across menopause stages

Jun 6, 2026 02:53PM Eli Lilly reports positive results for obesity drug retatrutide trials

Jun 5, 2026 07:38AM Morgan Stanley on Eli Lilly (LLY): 'We see ~7% upside to '26 M+Z ests'

Jun 5, 2026 07:05AM TD Cowen raises global GLP-1 sales forecast to $150B by 2030

Jun 4, 2026 07:00PM ADA 2026 preview: All eyes on these 2 stocks

Jun 4, 2026 08:03AM Weight Watchers integrates with Eli Lilly's LillyDirect platform

Jun 3, 2026 01:17PM Lilly cuts Germany investment plan in half over healthcare reforms

Jun 2, 2026 09:30AM Lilly to present hematology data at European meeting in Stockholm

Jun 1, 2026 11:35AM Camurus (CAMX) announces expansion of Lilly collaboration, decision extends Lilly's exclusive, global rights to Camurus' FluidCrystal technology

Jun 1, 2026 02:53AM Lilly's Retevmo reduces cancer recurrence risk by 83% in trial

May 31, 2026 11:21PM Hanmi Signs Licensing Deal with Lilly for sonefpeglutide

May 28, 2026 06:47AM CVS Adds Lilly's Zepbound To Preferred Drug List In Reversal

May 26, 2026 06:45AM Lilly acquires three infectious disease companies for up to $3.83 billion

May 26, 2026 06:40AM Eli Lilly & Co. (LLY) to buy three vaccine firms for up to $4B - WSJ

May 26, 2026 05:50AM Lilly's VERVE-102 reduces cholesterol by up to 62% in phase 1b trial

May 26, 2026 05:26AM Eli Lilly (LLY) PT Raised to $1,251 at BofA Securities

May 26, 2026 03:05AM Leerink Reiterates Outperform Rating on Eli Lilly (LLY)

May 22, 2026 09:54AM China holds roundtable with over 50 foreign pharmaceutical firms

May 22, 2026 09:25AM China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck

May 22, 2026 08:50AM Eli Lilly reports weight loss data for obesity drug in older adults

May 21, 2026 05:02PM Lilly to present oncology data at ASCO 2026 meeting

May 20, 2026 09:37AM Eli Lilly & Co. (LLY) Acquires Engage Biologics for Up to $202M in Cash

May 18, 2026 10:59AM Trump to unveil more discounted prescription drug options - CNBC

May 18, 2026 09:57AM Eli Lilly loses Supreme Court appeal of $194 million fraud award

May 13, 2026 09:24AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

May 13, 2026 05:57AM Eli Lilly launches Alzheimer's drug in India at $957 per vial

May 12, 2026 06:01PM Lilly reports weight maintenance with Foundayo and reduced-dose Zepbound

May 12, 2026 12:53PM FDA Commissioner Marty Makary to step down - Politico

May 8, 2026 12:04PM Health officials explore restrictions on certain SSRI antidepressants - Reuters

May 6, 2026 09:01AM Eli Lilly invests additional $4.5 billion in Indiana manufacturing sites

May 5, 2026 12:30PM Novo Nordisk reports Q1 earnings on Wednesday: Analysts flag key focus topics

May 5, 2026 06:48AM Lilly's Omvoh shows sustained disease remission in ulcerative colitis study

May 4, 2026 11:14AM Eli Lilly & Co. (LLY) Declares $1.73 Quarterly Dividend; 0.7% Yield

May 4, 2026 10:26AM RBC Capital on Eli Lilly (LLY): 'we think the sell-off is overdone'

May 4, 2026 09:27AM Goldman Sachs on Eli Lilly (LLY): 'see the stock weakness as an overreaction'

May 4, 2026 09:20AM Guggenheim on Cabaletta Bio (CABA): 'compelling evidence that CAR-T activity can be achieved without preconditioning'

May 4, 2026 09:15AM Bernstein: We're buyers of weakness in LLY

May 4, 2026 08:58AM Eli Lilly (LLY) PT Raised to $1,400 at Barclays, 'A remarkably strong quarter...and LLY's only just getting started'

May 4, 2026 08:57AM Wolfe Research Defending Eli Lilly (LLY) Amid 1.53% Drop: 'Faers For Foundayo Are Unfounded'

May 4, 2026 08:44AM Why Eli Lilly stock is down 3% today: FDA adverse event data explained

May 1, 2026 11:06AM Eli Lilly (LLY) PT Lowered to $1,133 at BofA Securities

View Older Stories